Dry powder inhalation of hemin to induce heme oxygenase expression in the lung

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 67, Issue 3, 2007, Pages 667-675

  Zijlstra, G S ^a   Brandsma, C A ^b   Harpe, M F H ^a   Van Dam, G M ^b   Slebos, D J ^b   Kerstjens, H A M ^b   De Boer, A H ^a   Frijlink, H W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dry powder inhalation; Fluorescent imaging; Heme oxygenase; Hemin; Mice; Spray drying

Indexed keywords

HEME OXYGENASE; HEMIN; RHODAMINE B; SODIUM HYDROXIDE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISPERSION; DOSE RESPONSE; DRUG FORMULATION; FEMALE; FRACTIONATION; HISTOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; POWDER; POWDER INHALER; PROTEIN EXPRESSION;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BLOTTING, WESTERN; CHEMISTRY, PHARMACEUTICAL; DESICCATION; ENZYME INDUCTION; FEMALE; FLUORESCENT DYES; HEME OXYGENASE-1; HEMIN; LUNG; MICE; MICE, INBRED A; MICROSCOPY, ELECTRON, SCANNING; POWDERS; RHODAMINES; SOLUBILITY;

EID: 35348881012     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.03.021     Document Type: Article

References (31)

1. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 4 (2000) 422-428
2. Otterbein L.E., and Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 6 (2000) L1029-L1037
3. Willis D., Moore A.R., Frederick R., and Willoughby D.A. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 1 (1996) 87-90
4. Carter E.P., Garat C., and Imamura M. Continual emerging roles of HO-1: protection against airway inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 1 (2004) L24-L25
5. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 4792 (1987) 1043-1046
6. Choi A.M., and Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell. Mol. Biol. 1 (1996) 9-19
7. Maestrelli P., Paska C., Saetta M., Turato G., Nowicki Y., Monti S., Formichi B., Miniati M., and Fabbri L.M. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur. Respir. J. 6 (2003) 971-976
8. Slebos D.J., Kerstjens H.A., Rutgers S.R., Kauffman H.F., Choi A.M., and Postma D.S. Haem oxygenase-1 expression is diminished in alveolar macrophages of patients with COPD. Eur. Respir. J. 4 (2004) 652-653 author reply 653
9. Repine J.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am. J. Respir. Crit. Care Med. 2 Pt 1 (1997) 341-357
10. Almolki A., Taille C., Martin G.F., Jose P.J., Zedda C., Conti M., Megret J., Henin D., Aubier M., and Boczkowski J. Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 1 (2004) L26-L34
11. Khan Z.A., Barbin Y.P., Cukiernik M., Adams P.C., and Chakrabarti S. Heme-oxygenase-mediated iron accumulation in the liver. Can. J. Physiol. Pharmacol. 7 (2004) 448-456
12. Barnes P.J., and Hansel T.T. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet 9438 (2004) 985
13. Horvath I., Donnelly L.E., Kiss A., Paredi P., Kharitonov S.A., and Barnes P.J. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 8 (1998) 668-672
14. Duddu S.P., Sisk S.A., Walter Y.H., Tarara T.E., Trimble K.R., Clark A.R., Eldon M.A., Elton R.C., Pickford M., Hirst P.H., Newman S.P., and Weers J.G. Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder. Pharm. Res. 5 (2002) 689-695
15. Dunbar C., Scheuch G., Sommerer K., DeLong M., Verma A., and Batycky R. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation. Int. J. Pharm. 1-2 (2002) 179-189
16. De Boer A.H., Le Brun P.P.H., van der Woude H.G., Hagedoorn P., Heijerman H.G., and Frijlink H.W. Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle. Eur. J. Pharm. Biopharm. 1 (2002) 17-24
17. Le Brun P.P.H., De Boer A.H., Mannes G.P., De Fraiture D.M., Brimicombe R.W., Touw D.J., Vinks A.A., Frijlink H.W., and Heijerman H.G. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. Eur. J. Pharm. Biopharm. 1 (2002) 25-32
18. De Boer A.H., Hagedoorn P., Westerman E.M., Le Brun P.P., Heijerman H.G., and Frijlink H.W. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer((R))) for high powder doses. Eur. J. Pharm. Sci. 3 (2006) 171-178
19. , (accessed 01.02.07).
20. Wu Y.S., Frijlink H.W., van Vliet L.J., Stokroos I., and van der Voort Maarschalk K. Location-dependent analysis of porosity and pore direction in tablets. Pharm. Res. 8 (2005) 1399-1405
21. Ridler T.W., and Calvard S. Picture tresholding using an iterative selection method. IEEE Trans. Syst. Man Cybern (1978) 630-632
22. Bauer J., and Fornnarino J. High-performance liquid chromatographic analysis of "available" hemin in hematin solutions. J. Chromatogr. (1984) 378-382
23. Withers P.C. Metabolic, respiratory and haematological adjustments of the little pocket mouse to circadian torpor cycles. Respir. Physiol. 3 (1977) 295-307
24. Fairchild G.A. Measurement of respiratory volume for virus retention studies in mice. Appl. Microbiol. 5 (1972) 812-818
25. Rabbani N.R., and Seville P.C. The influence of formulation components on the aerosolisation properties of spray-dried powders. J. Control. Release 1 (2005) 130-140
26. Zijlstra G.S., Hinrichs W.L.J., De Boer A.H., and Frijlink H.W. The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix. Eur. J. Pharm. Biopharm. 2 (2004) 139-149
27. Goldstein L., Teng Z.P., Zeserson E., Patel M., and Regan R.F. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J. Neurosci. Res. 1 (2003) 113-121
28. Wagener F.A., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., and Figdor C.G. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 3 (2003) 551-571
29. Attuwaybi B.O., Kozar R.A., Moore-Olufemi S.D., Sato N., Hassoun H.T., Weisbrodt N.W., and Moore F.A. Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J. Surg. Res. 1 (2004) 53-57
30. Wagener, Feldman E., de Witte T., and Abraham N.G. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc. Soc. Exp. Biol. Med. 3 (1997) 456-463
31. Wagener F.A., Eggert A., Boerman O.C., Oyen W.J., Verhofstad A., Abraham N.G., Adema G., van Kooyk Y., de Witte T., and Figdor C.G. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 6 (2001) 1802-1811